Global Med Technologies(R)' Systems Now in All 50 States
DENVER, Feb. 12 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has licensed its SafeTrace Tx(R) transfusion management system to Brattleboro Memorial Hospital of Vermont. Terms of the agreement were not disclosed.
Thomas F. Marcinek, President and COO for Global Med Technologies, stated, "The licensing of SafeTrace Tx to Brattleboro Memorial Hospital of Vermont is an exciting milestone for our Company. In addition to our client base in over 20 countries, Global Med's donor and transfusion management systems are now licensed to healthcare organizations in all 50 states and Puerto Rico. As our products and services continue to gain market share, both domestically and internationally, our clients' confidence in our products and our ability to meet their diverse needs is very gratifying."
SafeTrace Tx is transfusion management software which provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These powerful features will assist Brattleboro Memorial Hospital's technologists in selecting appropriate blood products for their patients and help to reduce waste and increase efficiency in their blood bank.
Wm. Scott Dustin, Senior Vice President of Sales and Marketing for Global Med Technologies, commented, "We are pleased that Brattleboro Memorial Hospital has chosen our Company to provide quality software and services for their blood bank. Our SafeTrace Tx product is a leader among transfusion management systems and we are pleased that it will be supporting the hospital's staff as they continue to provide quality healthcare to patients in their community."
About Brattleboro Memorial Hospital
Brattleboro Memorial Hospital ("BMH") is a modern, well-equipped and professionally staffed community hospital which has been serving greater Brattleboro, Vermont and the tri-state area since 1904. Throughout more than a century of caring for the community, BMH has kept abreast with medical technology and has drawn excellent physicians to their facility. The BMH medical staff boasts more than 100 board-certified physicians, active in both primary care and many specialties.
About Global Med Technologies(R), Inc.
Global Med Technologies, Inc. is an international medical software company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med's domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
Company Contact: Global Med Technologies, Inc. Michael I. Ruxin, M.D. (303) 238-2000 firstname.lastname@example.org Investor Contact: Global Med Technologies, Inc. Karen Davis, CFO (916) 404-8495 email@example.com
SOURCE Global Med Technologies
You May Also Like